Abbott will exclusively distribute and market Extensior in the country, becoming the second company to secure sole distribution rights for Novo's semaglutide portfolio in India, after Emcure Pharma.

AUSTIN, TX / ACCESS Newswire / March 2, 2026 / In modern metabolic medicine, few treatments have reshaped care like GLP-1 receptor agonists. If you are asking what is semaglutide, it is a prescription ...

Several leading Indian drugmakers have already secured regulatory approval or recommendations to produce and market generic ...

From Semaglip, Sematop, Semakind to Semastrike, Semaglyn and Semaril, the pipeline of upcoming Ozempic copycats reads like ...

The UK is one of the heaviest nations in Europe now with 64 per cent of the population overweight or obese, and one in four ...

NVO wins EU nod for a higher 7.2 mg Wegovy dose, unlocking stronger weight-loss results and a new step-up option for obesity care.

The Tennessee Poison Center is seeing a sharp increase in calls related to tirzepatide and semaglutide exposure over the last ...

Novo Nordisk stock fell over 16% Monday after it said its next-generation weight loss drug didn't meet its primary target.

Today's drugs come in injectable format, administered on a weekly basis. The one exception is the recently approved Wegovy ...

KwikPen® for single-patient use available from Lilly at $449 across all doses through the Lilly Employer Connect platform, with reduced cost-share ...

Eli Lilly and Company today announced the launch of its Employer Connect platform, introducing new options to help close the access gap in U.S. obesity care. Lilly's platform expands choice, ...

Consolidation of four doses may lower secondary packaging complexity and improve fill-finish throughput predictability, although Lilly has not quantified manufacturing efficiency gains. Multi-dose use ...